HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Poland Kick Starts 2019 With Three Rx-To-OTC Switches

Executive Summary

Clotrimazole, pyrantel, and ciclopirox olamine have been switched from prescription-to-OTC status by Poland's national drug regulator.
Advertisement

Related Content

FDA Has Model Drug Facts Labels For OTC Naloxone, Wants Switch Proposals
Polish Consumers Finding It Harder To Access OTC Drugs
Make Emergency Contraceptives GSL In The UK, Urge HRA Pharma And The British Pregnancy Advisory Service
Germany Begins The Year With Two Possible Rx-To-OTC Switches

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS148461

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel